These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26340801)

  • 1. Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.
    Ozolina A; Strike E; Nikitina-Zake L; Jaunalksne I; Krumina A; Lacis R; Bjertnaes LJ; Vanags I
    BMC Anesthesiol; 2015 Sep; 15():122. PubMed ID: 26340801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
    Ozolina A; Strike E; Jaunalksne I; Serova J; Romanova T; Zake LN; Sabelnikovs O; Vanags I
    Medicina (Kaunas); 2012; 48(10):515-20. PubMed ID: 23324247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
    Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
    Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J; Jelicic M; Stojkovic O
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
    Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
    Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
    Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
    Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
    Genomics; 2007 Mar; 89(3):362-9. PubMed ID: 17207964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
    Sirgo G; Morales P; Rello J
    Eur J Anaesthesiol; 2009 May; 26(5):404-11. PubMed ID: 19521296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy.
    Dušanović Pjević M; Beslac Bumbaširevic L; Vojvodic L; Grk M; Maksimović N; Damnjanović T; Novaković I; Kačar K; Pesic M; Perovic D; Savic M; Maksic V; Trickovic J; Jekic B
    J Pharm Pharm Sci; 2019; 22(1):142-149. PubMed ID: 31013014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH; Smolkin ME; Lamb JM; Brown NJ; Vaughan DE
    Clin Genet; 2002 Jul; 62(1):53-9. PubMed ID: 12123488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
    Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
    Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages.
    Buchholz T; Lohse P; Rogenhofer N; Kosian E; Pihusch R; Thaler CJ
    Hum Reprod; 2003 Nov; 18(11):2473-7. PubMed ID: 14585904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
    Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
    Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
    Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.